FDA Approved: MAXIDEX — Supplemental Application (Harrow Eye, LLC)

View source ↗

Summary

FDA approved a supplemental application for MAXIDEX (dexamethasone) by Harrow Eye, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conjunctivitis
• Inflammation of the Eye
• Postoperative Ocular Inflammation

Drugs mentioned

• Maxidex (dexamethasone 0.1%)

Snippet

SUPPL AP for MAXIDEX (DEXAMETHASONE)